VIVALDI ASCOT and Ethnography Study: protocol for a mixed-methods longitudinal study to evaluate the impact of COVID-19 and other respiratory infection outbreaks on care home residents' quality of life and psychosocial well-being.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
07 Aug 2024
Historique:
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 8 8 2024
Statut: epublish

Résumé

Older adults in care homes experienced some of the highest rates of mortality from SARS-CoV-2 globally and were subjected to strict and lengthy non-pharmaceutical interventions, which severely impacted their daily lives. The VIVALDI ASCOT and Ethnography Study aims to assess the impact of respiratory outbreaks on care home residents' quality of life, psychological well-being, loneliness, functional ability and use of space. This study is linked to the VIVALDI-CT, a randomised controlled trial of staff's asymptomatic testing and sickness payment support in care homes (ISRCTN13296529). This is a mixed-methods, longitudinal study of care home residents (65+) in Southeast England. Group 1-exposed includes residents from care homes with a recent COVID-19 or other respiratory infection outbreak. Group 2-non-exposed includes residents from care homes without a recent outbreak. The study has two components: (a) a mixed-methods longitudinal face-to-face interviews with 100 residents (n=50 from group 1 and n=50 from group 2) to assess the impact of outbreaks on residents' quality of life, psychological well-being, loneliness, functional ability and use of space at time 1 (study baseline) and time 2 (at 3-4 weeks after the first visit); (b) ethnographic observations in communal spaces of up to 10 care homes to understand how outbreaks and related restrictions to the use of space and social activities impact residents' well-being. The study will interview only care home residents who have the mental capacity to consent. Data will be compared and integrated to gain a more comprehensive understanding of the impact of outbreaks on residents' quality of life and well-being. The VIVALDI ASCOT and Ethnography Study obtained ethical approval from the Health Research Authority (HRA) Social Care REC (24/IEC08/0001). Only residents with the capacity to consent will be included in the study. Findings will be published in scientific journals.

Identifiants

pubmed: 39117401
pii: bmjopen-2024-088685
doi: 10.1136/bmjopen-2024-088685
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e088685

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: All the authors declare no financial relationships with any organisations that might have an interest in the submitted work and no other relationships or activities that could appear to have influenced the proposed work.

Auteurs

Lavinia Bertini (L)

Department of Clinical Neuroscience, Brighton and Sussex Medical School, Brighton, UK.
Department of Primary Care, Brighton and Sussex Medical School, Brighton, UK.

Nicola Schmidt-Renfree (N)

Department of Clinical Neuroscience, Brighton and Sussex Medical School, Brighton, UK.
Department of Primary Care, Brighton and Sussex Medical School, Brighton, UK.

James Blackstone (J)

Comprehensive Clinical Trials Unit, University College London, London, UK.

Oliver Stirrup (O)

Institute for Global Health, University College London, London, UK.

Natalie Adams (N)

Royal Free London NHS Foundation Trust, London, UK.
UCL Institute of Health Informatics, London, UK.

Iona Cullen-Stephenson (I)

Comprehensive Clinical Trials Unit, University College London, London, UK.

Maria Krutikov (M)

Institute of Health informatics, University College London, London, UK.

Ruth Leiser (R)

Department of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.

Lara Goscé (L)

Institute for Global Health, University College London, London, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Catherine Henderson (C)

Care Policy and Evaluation Centre, The London School of Economics and Political Science, London, UK.

Paul Flowers (P)

University of Strathclyde, Glasgow, UK.

Laura Shallcross (L)

Institute of Health informatics, University College London, London, UK.

Jackie A Cassell (JA)

Department of Primary Care, Brighton and Sussex Medical School, Brighton, UK.
UK Health Security Agency, London, UK.

Dorina Cadar (D)

Department of Clinical Neuroscience, Brighton and Sussex Medical School, Brighton, UK d.cadar@bsms.ac.uk.
Behavioural Scince and Health, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH